Filter
1506
Filtered Results: 1506
Text search:
drug
approval
Featured
Recommendations
105
New Publications
446
Language
Document type
No document type
913
Studies & Reports
253
Guidelines
186
Manuals
64
Strategic & Response Plan
35
Fact sheets
28
Training Material
15
Situation Updates
5
Resource Platforms
4
Infographics
2
Brochures
1
Countries / Regions
India
99
Kenya
47
Uganda
46
Global
42
Nigeria
39
South Africa
37
Malawi
35
Ethiopia
32
Nepal
32
Sierra Leone
30
Western and Central Europe
29
Myanmar / Burma
26
Liberia
25
Ukraine
25
Ghana
24
Bangladesh
24
Zambia
23
Tanzania
22
Rwanda
19
Latin America and the Carribbean
19
Namibia
17
Lesotho
17
Africa
15
Zimbabwe
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
10
Burkina Faso
9
Senegal
8
Philippines
8
Cambodia
8
Asia
8
Syria
6
Thailand
6
Tajikistan
6
Russia
6
USA
5
Pakistan
5
Mozambique
5
Benin
5
Cameroon
4
South Sudan
4
Germany
4
China
4
Indonesia
4
Peru
4
East and Southern Africa
4
Venezuela
4
Albania
4
Afghanistan
3
Eswatini/ Swaziland
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Georgia
3
Vietnam
3
Guinea
2
Somalia
2
Iraq
2
Central African Republic
2
Brazil
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Western Pacific Region
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Haiti
1
Lebanon
1
Turkey
1
Sudan
1
Argentina
1
Colombia
1
Libya
1
Madagascar
1
Sri Lanka
1
Chile
1
Yemen
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Southern Africa
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
662
Clinical Guidelines
127
Public Health
52
Women & Child Health
41
Pharmacy & Technologies
36
Key Resources
26
Capacity Building
12
Toolboxes
HIV
179
TB
142
AMR
111
COVID-19
82
Mental Health
79
Pharmacy
71
NTDs
42
Ebola
29
NCDs
28
Rapid Response
26
Caregiver
25
Planetary Health
17
Conflict
13
Global Health Education
13
Refugee
12
Health Financing Toolbox
12
Disability
11
Polio
6
Zika
6
Natural Hazards
5
Specific Hazards
4
Cholera
2
Social Ethics
1
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Violence against women and girls is widespread in the Region of the Americas, resulting in enormous consequences for the health and wellbeing of women and girls, their families and communities. These costs are unacceptable and they can be prevented through evidence-based action, including the health...
La violencia contra las mujeres y las niñas es generalizada en la Región de las Américas, y tiene enormes consecuencias para su salud y bienestar, así como el de sus familias y sus comunidades. Se trata de un costo inaceptable que puede ser prevenido mediante acciones basadas en la evidencia, pr...
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable of testing for priority foodborne hazards. The Pacif...
The application of digital health technology is growing at a rapid rate in Africa, with the goals of improving the delivery of healthcare services and more effectively reaching out to remote and underserved communities. The lack of enabling guidelines and standards across the continent, on the other...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
This checklist is for any organization or person supporting the routine use of evidence in
the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health coverage (UHC). Its importance is emphasized in WH...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The High-Level Panel on International Financial Accountability, Transparency and Integrity for Achieving the 2030 Agenda (FACTI Panel) was convened by the 74th President of United Nations General Assembly and the 75th President of the Economic and Social Council on 2 March 2020. The objective of the...
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor...
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one of the most serious public health burdens among the most deprived communities, have only recently drawn the atte...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the ...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
